Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00385164
Status:
UNKNOWN
Last Update Posted:
2017-07-25
First Post:
2006-10-04
Brief Title:
The Utility of FDG-PET for Radiation Treatment in NSCLC
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography FDG-PET for Radiation Treatment Planning in Non-Small Cell Lung Cancer NSCLC
Status:
UNKNOWN
Status Verified Date:
2011-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients planned for radical radiation for NSCLC will undergo conventional CT stimulation and also PETCT scans for definition of radiation target volumes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| E-20328 | None | None | None |